miR-193a-5p has been shown to induce G1 phase cell cycle arrest by targeting NUSAP1 in liver cancer cells, which in turn downregulates Cyclin E1, Cyclin D1, Cyclin B1, and Cyclin A2 and induces p21 expression [42]. This evidence concerns the gene CDKN1A and liver cancer.